Learn More
Medchemexpress LLC Linifanib | 796967-16-3 | 99.4% | C21H18FN5O | 200 MG

Supplier: Medchemexpress LLC HY50751200MG
Linifanib (ABT-869) is a potent, orally active, multi-target inhibitor of the VEGFR and PDGFR family. It demonstrates prominent antitumor activity and has significantly less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. Linifanib also acts as a specific miR-10b inhibitor, blocking miR-10b biogenesis.
- Potent and orally active multi-target inhibitor of VEGFR and PDGFR family
- Exhibits prominent antitumor activity
- Significantly less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases
- Acts as a specific miR-10b inhibitor, blocking miR-10b biogenesis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.